Table 2 Laboratory and radiological criteria of the studied patients
Variables | Total cases (100)* | |
|---|---|---|
CT data | no (%)* | |
• Mass | 80 (80%) | |
• Cavity | 8 (8%) | |
• Collapse | 8 (8%) | |
• Bilateral nodules | 6 (6%) | |
• Ground glass opacities | 8 (8%) | |
• Consolidation | 6 (6%) | |
• Thoracic lymph node | 98 (98%) | |
• Pleural effusion | 23 (23%) | |
Chest CT distribution of lung cancer | no (%)* | |
• Right upper lobe | 23 (23%) | |
• Right middle lobe | 35 (35%) | |
• Right lower lobe | 15 (15%) | |
• Left upper lobe | 22 (22%) | |
• Left lower lobe | 8 (8%) | |
• Bilateral | 6 (6%) | |
Total laboratory results: | Mean ± SD | Range: |
• WBCS (× 103) | 10.02 ± 4.11 | (2.6–21.5) |
• Lymphocytes (%) | 25.77 ± 10.70 | (4.5–56) |
• Neutrophils (%) | 75.00 ± 82.29 | (36.05–81.3) |
• Eosinophils (%) | 1.01 ± 0.89 | (0.01–4) |